May toxicity of amiodarone be prevented by antioxidants? A cell-culture study
Open Access
- 28 June 2012
- journal article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 61
Abstract
Atrial Fibrillation is the most common arrhythmia encountered following cardiac surgery. The most commonly administered drug used in treatment and prophylaxis is amiodarone which has several toxic effects on major organ functions. There are few clinical data concerning prevention of toxic effects and there is no routinely suggested agent. The aim of this study is to document the cytotoxic effects of amiodarone on cell culture media and compare the cytoprotective effects of commonly used antioxidant agents.Keywords
This publication has 27 references indexed in Scilit:
- Cytotoxicity effects of amiodarone on cultured cellsExperimental and Toxicologic Pathology, 2012
- Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administrationFree Radical Biology and Medicine, 2011
- Mechanisms of termination and prevention of atrial fibrillation by drug therapyPharmacology & Therapeutics, 2011
- The Cytotoxic Effect of Nasodren Nasal Spray (Cyclamen Europaeum Extract) in L929 Fibroblastic Cell CultureTurkiye Klinikleri Journal of Medical Sciences, 2011
- Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in ratsIndian Journal of Pharmacology, 2011
- Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic reviewJournal of Cardiothoracic Surgery, 2010
- Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillationInternational Journal of Cardiology, 2010
- Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammationInternational Journal of Cardiology, 2005
- Attenuation of Amiodarone-Induced Pulmonary Fibrosis by Vitamin E Is Associated with Suppression of Transforming Growth Factor-β1 Gene Expression but Not Prevention of Mitochondrial DysfunctionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983